Literature DB >> 24007975

Intracranial atherosclerosis.

Adnan I Qureshi1, Louis R Caplan2.   

Abstract

Atherosclerotic disease often involves the intracranial arteries including those encased by cranial bones and dura, and those located in the subarachnoid space. Age, hypertension, and diabetes mellitus are independent risk factors for intracranial atherosclerosis. Intracranial atherosclerosis can result in thromboembolism with or without hypoperfusion leading to transient or permanent cerebral ischaemic events. High rates of recurrent ischaemic stroke and other cardiovascular events mandate early diagnosis and treatment. Present treatment is based on a combination of antiplatelet drugs, optimisation of blood pressure and LDL cholesterol values, and intracranial angioplasty or stent placement, or both, in selected patients.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24007975     DOI: 10.1016/S0140-6736(13)61088-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  101 in total

1.  New developments in clinical ischemic stroke prevention and treatment and their imaging implications.

Authors:  Jeremy J Heit; Max Wintermark
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-14       Impact factor: 6.200

2.  When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy.

Authors:  Kristy Yuan; Anthony S Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

3.  Prevalence of Intracranial Atherosclerotic Stenosis Using High-Resolution Magnetic Resonance Angiography in the General Population: The Atherosclerosis Risk in Communities Study.

Authors:  Muhammad Fareed K Suri; Ye Qiao; Xiaoye Ma; Eliseo Guallar; Jincheng Zhou; Yiyi Zhang; Li Liu; Haitao Chu; Adnan I Qureshi; Alvaro Alonso; Aaron R Folsom; Bruce A Wasserman
Journal:  Stroke       Date:  2016-04-07       Impact factor: 7.914

4.  Imaging the intracranial atherosclerotic vessel wall using 7T MRI: initial comparison with histopathology.

Authors:  A G van der Kolk; J J M Zwanenburg; N P Denswil; A Vink; W G M Spliet; M J A P Daemen; F Visser; D W J Klomp; P R Luijten; J Hendrikse
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-04       Impact factor: 3.825

5.  Outcomes after stenting for symptomatic intracranial arterial stenosis: a systematic review and meta-analysis.

Authors:  Tao Wang; Kun Yang; Jichang Luo; Peng Gao; Yan Ma; Yabing Wang; Long Li; Yiran Liu; Yao Feng; Xue Wang; Liqun Jiao
Journal:  J Neurol       Date:  2019-01-05       Impact factor: 4.849

Review 6.  Neurovascular and Cognitive Dysfunction in Hypertension.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

Review 7.  Intracranial atherosclerotic disease.

Authors:  Yuan Wang; Ran Meng; Gang Liu; Catherine Cao; Fenghua Chen; Kunlin Jin; Xunming Ji; Guodong Cao
Journal:  Neurobiol Dis       Date:  2018-11-12       Impact factor: 5.996

Review 8.  Top 10 cardiovascular therapies and interventions for the next decade.

Authors:  Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

Review 9.  Internal carotid artery stenting for intracranial atherosclerosis.

Authors:  Joshua W Osbun; Louis J Kim
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Oct-Dec

10.  Joint intracranial and carotid vessel wall imaging in 5 minutes using compressed sensing accelerated DANTE-SPACE.

Authors:  Sen Jia; Lei Zhang; Lijie Ren; Yulong Qi; Jinhao Ly; Na Zhang; Ye Li; Xin Liu; Hairong Zheng; Dong Liang; Yiu-Cho Chung
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.